Afamelanotide implants and narrow-band ultraviolet B phototherapy for the treatment of nonsegmental vitiligo in Asians

J Am Acad Dermatol. 2020 Jun;82(6):1517-1519. doi: 10.1016/j.jaad.2020.01.035. Epub 2020 Jan 25.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Asian People
  • Combined Modality Therapy
  • Dermatologic Agents*
  • Double-Blind Method
  • Drug Implants
  • Humans
  • Time Factors
  • Treatment Outcome
  • Ultraviolet Therapy* / adverse effects
  • Ultraviolet Therapy* / methods
  • Vitiligo / therapy*
  • alpha-MSH / adverse effects
  • alpha-MSH / analogs & derivatives*
  • alpha-MSH / therapeutic use

Substances

  • Dermatologic Agents
  • Drug Implants
  • alpha-MSH
  • afamelanotide